Provence Wealth Management Group’s Pfizer PFE Stock Holding History

Provence Wealth Management Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$261K	Buy	9,056 +397	+5%	+$12K	0.14%	138
2023 Q3	$287K	Buy	8,659 +1,143	+15%	+$40.4K	0.18%	110
2023 Q2	$276K	Sell	7,516 -358	-5%	-$13.9K	0.16%	120
2023 Q1	$321K	Buy	7,874 +1,343	+21%	+$58K	0.21%	96
2022 Q4	$335K	Buy	+6,531	New	+$313K	0.27%	77

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Provence Wealth Management Group's PFE Position: Q4 2023 in Review

Provence Wealth Management Group increased its Pfizer (PFE) stake by 4.6% in Q4 2023, buying an estimated $12K and bringing the position to 9,056 shares worth $261K. The position accounts for 0.14% of the portfolio, ranked #138.

Provence Wealth Management Group first reported a position in PFE in Q4 2022 and has held it in 5 quarters since. The position peaked at $335K in Q4 2022. 2,938 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Provence Wealth Management Group held 9,056 shares of Pfizer worth $261K as of Q4 2023.
Provence Wealth Management Group bought 397 Pfizer shares in Q4 2023, an estimated $12K.
Pfizer made up 0.14% of Provence Wealth Management Group's portfolio in Q4 2023, its #138 holding.
Provence Wealth Management Group first reported a position in Pfizer in Q4 2022 and has held it in 5 quarters since.
Provence Wealth Management Group's Pfizer position peaked at $335K in Q4 2022.
2,938 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Provence Wealth Management Group's 13F filing for Q4 2023, filed 6 Feb 2024.